These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 15694564)

  • 1. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
    Bélanger S; Coulombe G; Carmant L
    Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
    Hosford DA; Wang Y
    Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy.
    Wong IC; Chadwick DW; Fenwick PB; Mawer GE; Sander JW
    Epilepsia; 1999 Oct; 40(10):1439-45. PubMed ID: 10528941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine.
    Sethi A; Chandra D; Puri V; Mallika V
    Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
    Schapel G; Chadwick D
    Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE
    Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy.
    Kluger G; Berz K; Holthausen H
    Eur J Paediatr Neurol; 2001; 5(1):37-40. PubMed ID: 11277363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom.
    Wong IC; Mawer GE; Sander JW
    Epilepsia; 2001 Feb; 42(2):237-44. PubMed ID: 11240596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
    Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of lamotrigine and vigabatrin in drug-resistant epilepsies of childhood.
    Dimova PS; Korinthenberg R
    Pediatr Neurol; 1999 Nov; 21(5):802-7. PubMed ID: 10593670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of lamotrigine and vigabatrin treatment in children with severe epilepsy.
    Schapel GJ; Wallace SJ; Gordon GS
    Seizure; 1997 Dec; 6(6):479-83. PubMed ID: 9530945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epilepsy in children: the evidence for new antiepileptic drugs.
    Verdru P
    Acta Neurol Scand Suppl; 2005; 181():17-20. PubMed ID: 16238703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD; Wong IC; Polizzi G; Sander JW
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.